| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.096 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |